Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 180 clinical trials
Featured trial
Does your stomach pain and diarrhea come from Crohn's disease?

Does your stomach pain and diarrhea come from Crohn's disease?

  • 110 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Irritable Bowel Syndrome with Constipation Clinical Trial

Irritable Bowel Syndrome with Constipation Clinical Trial

  • 218 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Irritable Bowel Syndrome with Constipation (Synergy Pharmaceuticals)

Irritable Bowel Syndrome with Constipation (Synergy Pharmaceuticals)

  • 80 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Irritable Bowel Syndrome with Diarrhea

Irritable Bowel Syndrome with Diarrhea

  • 804 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Are you at risk for C.diff? • Do you have an upcoming SURGERY, requiring you to be hospitalized for several days? • Have you been HOSPITALIZED TWICE in the last year and received antibiotics? • Are you 50 years of age or older?

Are you at risk for C.diff? • Do you have an upcoming SURGERY, requiring you to be hospitalized for several days? • Have you been HOSPITALIZED TWICE in the last year and received antibiotics? • Are you 50 years of age or older?

  • 280 views
  • 23 Nov, 2020
  • 1 location
Featured trial
IBS...Irritable Bowel Syndrome

IBS...Irritable Bowel Syndrome

  • 1053 views
  • 08 Nov, 2020
  • 2 locations
Featured trial
Uterine Fibroids with Heavy Menstrual Periods

Uterine Fibroids with Heavy Menstrual Periods

  • 597 views
  • 25 Mar, 2021
  • 1 location
Effects of High FIO2 on Post-ERCP Pancreatitis.

Post-ERCP pancreatitis is one of the most common complications accounting for substantial morbidity and mortality. The incidence of post-ERCP pancreatitis (PEP) has been studied in several large clinical trials and ranges from 1.6-15%. However most studies have demonstrated rates around 5%. This complication alone is estimated to cost the US …

  • 0 views
  • 29 May, 2021
  • 1 location
Comparison of LCBDE vs ERCP + LC for Choledocholithiasis

Protection of Oddi's sphincter remains a huge argument especially in the long term complications like common bile duct stone recurrence or cholangitis after ERCP, which determined to destroy the sphincter of Oddi. The purpose of this study is to compare the long-term outcomes of ERCP sequential LC versus LCBDE for …

  • 0 views
  • 19 Apr, 2022
  • 12 locations
Ethosuximide to Treat IBS (IBSET)

Abdominal pain remains the most deleterious symptom for patients with irritable bowel syndrome (IBS) and is causing a significant alteration of their quality of life. The visceral

abdominal pain
antispasmodic
  • 22 views
  • 03 May, 2022
  • 1 location